Therapeutic strategies for patients with social phobia

References

• Agras S W, Silvester D, Oliveau D. The epidemiology of common fears and phobias. Comp Psychiatry 1969; 10: 439–47
   Google Scholar
• Heimberg R E, Liebowitz M R, Hope D A, Schneier F S. Social phobia. Diagnosis, assessment, and treatment. Guilford Press, New York 1996
   Google Scholar
• Turner S M, Beidel D C, Dancu C V, et al. Psychopathology of social phobia and comparison to avoidant personality disorder. J Abnorm Psychol 1986; 95: 389–94
   PubMed Web of Science ®Google Scholar
• Kessler R C, McGonagle K H, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51: 8–19
   PubMed Web of Science ®Google Scholar
• Turner S M, Beidel D C, Townsley R M. Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder. J Abnorm Psychol 1992; 101: 326–31
   PubMed Web of Science ®Google Scholar
• Judd L L. Social phobia: a clinical overview. J Clin Psychiatry 1994; 55: 5–9
   PubMedGoogle Scholar
• Schneier F R, Johnson J, Hornig C D, et al. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992; 49: 282–7
   PubMed Web of Science ®Google Scholar
• Liebowitz M R, Gorman J M, Fyer A J, et al. Social phobia. Arch Gen Psychiatry 1985; 42: 729–36
   PubMed Web of Science ®Google Scholar
• Boerner R J, Möller H J. Pharmakotherapie der sozialen Phobic. Nervenheilkunde 1996; 15: 459–63
   Google Scholar
• Den Boer J A, van Vliet I M, Westenberg H GM. Recent developments in the psychopharmacology of social phobia. Eur Arch Psychiatry Clin Neurosci 1995; 224: 309–16
   Google Scholar
• International Multicenter Clinical Trial Group on Moclobemide in Social Phobia (1997) Moclobemide in social phobia: A double-blind, placebo-controlled clinical study. Eur Arch Psychiatry Clin Neurosci, 247: 71–80
   PubMedGoogle Scholar
• Bassler N. Analytische Psychotherapie und Psychodynamik von sozialen Angsten. Psychotherapie und Psychopharmaka, P Buchheim. Schattauer, Stuttgart 1997; 93–101
   Google Scholar
• Heimberg R G, Salzman D G, Holt C S, et al. Cognitive-behavioral group treatment for social phobia: effectiveness at five-year follow-up. Cogn Ther Res 1993; 17: 325–39
   Web of Science ®Google Scholar
• Newman M G, Hofmann S G, Trabert W, et al. Does behavioral treatment of social phobia lead to cognitive changes?. Behav Ther 1994; 25: 503–17
   Google Scholar
• Butler G, Cullington A, Munby M, et al. Exposure and anxiety management in the treatment of social phobia. J Consult Clin Psychol 1984; 52: 642–50
   PubMed Web of Science ®Google Scholar
• Emmelkamp P MG, Mersch P PA, Vissia E, van der Helm M. Social phobia: A comparative evaluation of cognitive and behavioural interventions. Behaviour Res Ther 1985; 23: 365–9
   PubMed Web of Science ®Google Scholar
• Mattick R P, Peters L. Treatment of severe social phobia: effects of guided exposure with and without cognitive restructuring. J Consult Clin Psychol 1988; 56: 251–60
   PubMed Web of Science ®Google Scholar
• Mattick R P, Peters L, Clarke J C. Exposure and cognitive restructuring for severe social phobia. Behavior Ther 1989; 20: 3–23
   Web of Science ®Google Scholar
• Stravynski A, Marks I, Yule W. Social skill problems in neurotic outpatients: social skills training with and without cognitive modification. Arch Gen Psychiatry 1982; 39: 1378–85
   PubMed Web of Science ®Google Scholar
• Mersch P PA, Emmelkamp P MG, Lips C. Social phobia: individual response patterns and the long-term effects of behavioral and cognitive interventions. A follow-up study. Behav Res Ther 1991; 29: 357–62
   PubMed Web of Science ®Google Scholar
• Wlazlo Z, Schroeder-Hartwig K, Hand I, et al. Exposure in vivo vs social skills training for social phobia: long-term outcome and differential effects. Behav Res Ther 1990; 28: 181–93
   PubMed Web of Science ®Google Scholar
• Scholing A, Emmelkamp P MG. Cognitive and behavioral treatment of fear of blushing, sweating or trembling. Behav Res Ther 1993; 31: 155–70
   PubMedGoogle Scholar
• Scholing A, Emmelkamp P MG. Exposure with and without cognitive therapy for generalized social phobia: effects of individual and group treatment. Behav Res Ther 1993; 31: 667–81
   PubMedGoogle Scholar
• Turner S M, Beidel D C, Cooky M R, et al. A multi-component behavioral treatment for social phobia: social effectiveness therapy. Behav Res Ther 1994; 32: 381–90
   PubMed Web of Science ®Google Scholar
• Turner S M, Beidel D C, Cooley-Quille M R. Two-year follow-up of social phobics treated with social effectiveness therapy. Behav Res Ther 1995; 33: 553–5
   PubMedGoogle Scholar
• Davidson J RT, Ford S M, Smith R D, et al. Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 1991; 52: 16–20
   PubMedGoogle Scholar
• Katzelnick D J, Kobak K A, Greist J H, et al. Sertraline in social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995; 152: 1368–71
   PubMed Web of Science ®Google Scholar
• Stein M B, Charter M J, Kroft C DL, et al (1994) Social phobia pharmacotherapy with paroxetine: open-label treatment and double-blind placebo-substitution studies. Presented at 33rd ACNP Congress, Puerto Rico, 1994
   Google Scholar
• Versiani M, Nardi A E, Mundin F D, et al. Pharmacotherapy in social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1992; 161: 353–60
   PubMed Web of Science ®Google Scholar
• Van Vliet I M, den Boer J A, Westenberg H GM. Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, selective MAO inhibitors. Eur Neuropharmacol 1992; 2: 21–9
   PubMedGoogle Scholar
• Nutt D, Montgomery S A. Moclobemide in the treatment of social phobia. Int Clin Psychopharmacol 1996; 11: 77–82
   PubMedGoogle Scholar
• Versiani M, Nardi A E, Mundin F D, et al. The long-term treatment of social phobia with moclobemide. Int Clin Psychopharmacol 1996; 11: 83–8
   PubMedGoogle Scholar
• Schneier F R, Goetz D, Campeas R, et al. Placebo-controlled trial of moclobemide in social phobia. Br J Psychiatry 1998; 172: 70–77
   PubMed Web of Science ®Google Scholar
• Falloon I R, Lloyd G G, Harpin R E. The treatment of social phobia: real-life rehearsal with nonprofessional therapists. J Nerv Ment Dis 1981; 169: 180–4
   PubMed Web of Science ®Google Scholar
• Gelernter C S, Uhde T W, Cimbolic P, et al. Cognitive-behavioral and pharmacological treatment of social phobia. Arch Gen Psychiatry 1991; 48: 938–45
   PubMed Web of Science ®Google Scholar
• Clark D B, Agras W S. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 1991; 148: 598–605
   PubMed Web of Science ®Google Scholar
• Heimberg R G, Dodge C S, Hope D A, et al. Cognitive behavioral treatment for social phobia: comparison to a credible placebo control. Cogn Ther Res 1990; 14: 1–23
   Web of Science ®Google Scholar
• Boerner R J, Möller H J. Depression and anxiety disorders — epidemiology, theoretical concepts and therapy potentials in cases of comorbidity. Int J Psychiatry Clin Prac 1998; 2, (in press).
   PubMedGoogle Scholar